Location History:
- Lafayette, IN (US) (1997 - 1998)
- West Layayette, IN (US) (2005)
- West Lafayette, IN (US) (1990 - 2015)
- Carmel, IN (US) (2018 - 2019)
Company Filing History:
18 out of 2,664 
12 out of 68 
1 out of 777 
Years Active: 1990-2019
Title: The Innovative Contributions of Fred E. Regnier
Introduction: Fred E. Regnier, located in West Lafayette, IN, has made significant strides in the field of biotechnology with a remarkable portfolio of 34 patents. His innovations primarily focus on the analysis and purification of biological samples, enhancing the accuracy of mass spectrometric analysis.
Latest Patents: Among his latest contributions are two notable patents titled "Method for analyzing samples of biological fluid and apparatus for performing the same." These inventions relate to continuous or near-continuous techniques for the separation and purification of biological samples. By utilizing a transport agent with a core domain and a targeted binding domain, his methods aim to minimize non-targeted analytes, allowing for a more efficient analysis of specific analytes of interest. The transport agents exceed 200 kiloDaltons or 10 nm, combined with size-exclusion based chromatography to effectively separate target-analyte complexes from non-targeted substances.
Career Highlights: Fred has held pivotal roles in esteemed organizations such as the Purdue Research Foundation and Perseptive Biosystems Inc. His expertise has significantly impacted the advancement of biotechnology and analytical chemistry, making him a key figure in these fields.
Collaborations: Throughout his career, Fred has collaborated with esteemed colleagues, including Noubar Boghos Afeyan and Robert C. Dean, Jr. Their partnerships have fostered innovation and driven the development of groundbreaking technologies within the industry.
Conclusion: Fred E. Regnier stands out as a pioneering inventor in the realm of biological analysis. With 34 patents to his name and a commitment to improving methodologies for sample purification and analysis, he continues to influence the future of biotechnology. His collaborative spirit and dedication to innovation make him a valuable asset to the scientific community.